CN Stock MarketDetailed Quotes

600329 Tianjin Pharmaceutical Da Ren Tang Group Corporation

Watchlist
  • 35.79
  • -0.67-1.84%
Market Closed May 17 15:00 CST
27.56BMarket Cap28.31P/E (TTM)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tianjin Pharmaceutical Da Ren Tang Group Corporation Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 30, 2024

Revenue(YoY)

2.09B

-3.19%
EPS(YoY)

0.50

-3.85%
Analyst Rating

Strong Buy

May 17, 2024

Tianjin Pharmaceutical Da Ren Tang Group Corporation Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 9.961B--
--2024/FY-- / 9.053B--
Mar 30, 20242023/FY8.222B / 8.549B--
Mar 31, 20232022/FY8.249B / 7.337B--
Mar 31, 20212020/FY6.604B / 7.727B--
--2019/FY6.994B / 7.026B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 9.961B--
--2024/FY-- / 9.053B--
Mar 30, 20242023/FY8.222B / 8.549B--
Mar 31, 20232022/FY8.249B / 7.337B--
Mar 31, 20212020/FY6.604B / 7.727B--
--2019/FY6.994B / 7.026B--
--------
--------
--------
--------

Unlock Free Earnings Estimates

Tianjin Pharmaceutical Da Ren Tang Group Corporation Earnings Reports

  • Daren Tang 2024 First Quarter Report

    Apr 30 00:00

  • Darren Tang's 2023 Annual Report Summary

    Mar 30 00:00

  • Daren Tang Annual Report 2023

    Mar 30 00:00

  • Tat Ren Tang\'s 2023 Third Quarter Report

    Oct 31, 2023 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 17, 2024

    Strong Buy

    • Strong Buy

      82.35%

    • Buy

      17.65%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg